做爰xxxⅹ性生交,色屁屁影院免费观看,亚洲午夜高清国产拍在线观看,亲嘴揉胸口激烈视频,中文字幕在线有码观看,激情大尺度同志小说,波多野结衣博客,与亲女洗澡时伦了2次,国产三级在线一区二区

Dr. Hei is the CMO at Zai Lab where he oversees the clinical development and portfolio strategy for all the oncology projects.? Prior to Zai Lab, Dr. Hei was the Corporate VP and CMO at Qilu Pharmaceuticals where he led the overall clinical development functions and supported business development and strategic alliances. ?Previously, Dr. Hei worked at the San Diego-based biotechnology company Ambrx Inc. for more than 2 years as the CMO responsible for the clinical strategy and operations, focusing on antibody-drug conjugates (ADCs) and CD3-based biospecifics.? Prior to Ambrx, Dr. Hei had worked at Amgen for more than 9 years before joining Ambrx, initially as the Head of Oncology Medical Affairs, and subsequently as an Executive Medical Director in Oncology Global Development in the capacity of a group or project leader for several oncology pipeline molecules and marketed products including the small molecules VEGF inhibitor motesanib and monoclonal antibodies targeting the death receptor DR4/5 (conatumumab) or the EGFR (panitumumab or Vectibix?).? Additionally, during his tenure at Amgen, Dr. Hei built the clinical medical teams for Amgen China in Shanghai and led the product development and clinical operations function for Amgen China.? Before Amgen, Dr. Hei worked for a few years at Novartis oncology as the Senior Global Brand Medical Director/Executive Director leading the clinical development and medical affairs teams for zoledronic acid (Zometa?), and for a few years at Roche Laboratories as the oncology Medical Director supporting capecitabine (Xeloda?) and other oncology projects. ?